Liraglutide and semaglutide are not the same medication, but they are closely related. Both belong to the same drug class (GLP-1 receptor agonists), both are injectable treatments derived from the same human gut hormone, and both are used for type 2 diabetes and weight management. The key differences come down to how long each drug stays active in your body, how often you take it, and how much weight you can expect to lose.
How They’re Related
Both liraglutide and semaglutide are synthetic versions of a natural hormone called GLP-1, which your gut releases after eating. This hormone tells your pancreas to produce insulin, slows digestion, and signals your brain that you’re full. The natural version breaks down in minutes, so both drugs were engineered with a fatty acid chain that lets them latch onto a protein in your blood (albumin), keeping them circulating much longer.
Think of them as two generations of the same idea. Liraglutide came first, and semaglutide was developed later with modifications that make it last dramatically longer in the body.
The Half-Life Gap Changes Everything
The most important practical difference is how long each drug remains active. Liraglutide has a half-life of about 13 hours, which means you need to inject it once every day. Semaglutide has a half-life of roughly 160 hours, about 12 times longer, so a single weekly injection keeps steady levels in your bloodstream.
This difference in staying power affects more than convenience. Because semaglutide maintains more consistent drug levels throughout the week, it tends to produce stronger effects on appetite, blood sugar, and body weight.
Brand Names and What They Treat
Each drug is sold under different brand names depending on whether it’s prescribed for diabetes or weight loss:
- Liraglutide: Victoza (for type 2 diabetes) and Saxenda (for weight management)
- Semaglutide: Ozempic (injectable, for type 2 diabetes), Wegovy (injectable, for weight management), and Rybelsus (oral tablet, for type 2 diabetes)
Semaglutide is also available as a daily pill for diabetes, making it the only GLP-1 drug with an oral option. Liraglutide is injection-only.
Weight Loss: Semaglutide Pulls Ahead
Both drugs help with weight loss, but semaglutide produces significantly better results at the doses approved for weight management. In clinical trials, 86 to 89% of people taking semaglutide 2.4 mg weekly lost more than 5% of their body weight. Between 69 and 79% lost more than 10%, and roughly half to two-thirds lost more than 15%.
Liraglutide’s numbers at its weight-loss dose (3.0 mg daily) are more modest. About 48 to 76% of patients lost more than 5% of their body weight, 20 to 46% lost more than 10%, and only 8 to 28% reached the 15% threshold. Even at lower diabetes-focused doses, studies have found that semaglutide 0.2 mg once daily outperformed liraglutide 3.0 mg daily for weight reduction.
Blood Sugar Control
For people with type 2 diabetes, both drugs lower blood sugar effectively, but semaglutide again shows a measurable edge. A meta-analysis published in Frontiers in Pharmacology found that semaglutide significantly reduced HbA1c (the marker of average blood sugar over three months) compared to liraglutide. That translates to fewer blood sugar spikes and better long-term glucose management on the same class of medication.
Heart Health Benefits
Both drugs have been shown to reduce the risk of major cardiovascular events like heart attack, stroke, and cardiovascular death in people with type 2 diabetes. However, an indirect comparison across the major cardiovascular trials (LEADER for liraglutide, SUSTAIN 6 and PIONEER 6 for semaglutide) found that semaglutide reduced the risk of these events by 22 to 27% more than liraglutide, depending on the population studied.
Dosing and Titration Schedules
Both drugs require a gradual dose increase to minimize nausea and other gastrointestinal side effects, but the timelines differ. Liraglutide starts at 0.6 mg and increases by 0.6 mg each week until reaching the target dose, which means you could reach the full weight-management dose of 3.0 mg in about five weeks. Semaglutide injections start at 0.25 mg and step up every four weeks (0.25, 0.5, 1.0, 1.7, then 2.4 mg for weight loss), so reaching the top dose takes about 16 to 20 weeks.
The slower ramp-up with semaglutide can feel frustrating, but it helps your body adjust to the stronger, longer-acting drug and reduces the chance of severe nausea early on.
Side Effects Are Similar
Because both drugs work through the same receptor, their side effect profiles overlap heavily. Nausea, vomiting, diarrhea, and constipation are the most common complaints with both. These effects are typically worst during dose increases and tend to fade over weeks. Since semaglutide is more potent and stays in the body longer, some people find its gastrointestinal effects harder to manage, particularly at higher doses.
Cost and Generic Availability
Brand-name versions of both drugs are expensive, but liraglutide now has a cost advantage. The FDA approved a generic version of Victoza (for diabetes), and in August 2025, Teva Pharmaceuticals launched a generic version of Saxenda (for weight loss), making it the first generic GLP-1 available for weight management. No generic version of semaglutide is currently available in the United States.
This price gap may matter if your insurance doesn’t cover GLP-1 medications or if you’re paying out of pocket. Generic liraglutide won’t match semaglutide’s efficacy numbers, but it offers a more affordable entry into the same drug class.
Switching From One to the Other
If you’re already taking liraglutide and considering a switch to semaglutide, guidelines from family medicine organizations recommend stopping liraglutide and starting semaglutide the next day, since you’re moving from a daily to a weekly injection. Your prescriber will typically start you at an equivalent or slightly lower semaglutide dose and titrate up from there. The transition is straightforward because the drugs work on the same receptor, but the dose adjustment period still applies to give your body time to adapt to semaglutide’s longer duration of action.